AuntMinnie.com staff writersAIRamSoft integrates workflow AI from Alpha NodusRamSoftRamSoft and Alpha Nodus have entered an agreement under which Rasmsoft will integrate Alpha Nodus’ Gravity AI workflow management software.March 26, 2025AIEvident Vascular moves toward FDA clearance with Series B financingEvident Vascular has added new investors at the close of a Series B financing round to support its efforts to secure U.S. FDA clearance.March 25, 2025Imaging InformaticsAikenist secures 510(k) clearance for AI PACS and RIS systemIndia-based Aikenist said the U.S. FDA clearance of the device allows the company to expand into North America.March 25, 2025Molecular ImagingEckert & Ziegler and Actinium ink Ac-225 agreementActinium will continue developing its lead radiopharmaceutical product Actimab-A.March 25, 2025Radiology EducationDiagnostic radiology positions fall short of 100% filledMore radiology residency positions were filled at Match Day 2025 than in previous years, but a few spots remained open.March 24, 2025Digital X-RayKA Imaging, MinXray to assist with medical x-ray in space initiativeCanadian x-ray manufacturer KA Imaging and partner MinXray will assist with the medical x-ray in space research via a project called SpaceXray.March 24, 2025UltrasoundFujifilm Healthcare Americas inks partnership with Us2.aiFujifilm has partnered with Us2.ai to equip Fujifilm's Lisendo 800 cardiovascular ultrasound system with Us2.ai's AI-driven echocardiography software.March 24, 2025MRIQuibim’s QP-Prostate cleared for diagnosing prostate cancerQuibim has received clearance from the U.S. Food and Drug Administration (FDA) for use of its QP-Prostate MRI software to help detect and diagnose prostate cancer.March 21, 2025Molecular ImagingCanadian province, Siemens begin diagnostic imaging enhancement programSiemens HealthineersSiemens Healthineers currently provides 100% of Alberta’s conventional external beam radiation therapy fleet and more.March 21, 2025Nuclear MedicineFDA greenlights Telix NDA for prostate imaging agent GozellixThe U.S. Food and Drug Administration (FDA) has approved a new drug application (NDA) for Telix's TLX007-CDx for prostate cancer imaging.March 21, 2025Previous PagePage 85 of 235Next PageTop StoriesCTNew benchmark helps monitor cumulative CT radiation doseThe findings highlight the need for systematic dose tracking and rigorous justification of imaging.Radiation Oncology/TherapyStudy questions routine use of radiotherapy after bone surgeryUltrasoundCEUS outshines color Doppler imaging for indeterminate kidney lesionsWomens ImagingWomen's Imaging MinnieCast, Episode 2: Risk-based vs. annual mammography screening, part 1Digital X-RayChest x-rays reveal atherosclerosis in patients undergoing amputations